Gemmer Asset Management LLC Abb Vie Inc. Transaction History

Gemmer Asset Management LLC

$969 Million
Q3 2024

A detailed history of Gemmer Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Gemmer Asset Management LLC holds 2,510 shares of ABBV stock, worth $459,530. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,510

Previous 2,616 4.05%

Holding current value

$459,530

Previous $448,000 10.49%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $17,367 - $21,128	-106 Reduced 4.05%	2,510 $495,000
Q2 2024 Jul 15, 2024	BUY	$154.79 - $180.76 $154 - $180	1 Added 0.04%	2,616 $448,000
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $11,347 - $12,929	-71 Reduced 2.64%	2,615 $476,000
Q4 2023 Jan 17, 2024	BUY	$137.6 - $154.97 $7,568 - $8,523	55 Added 2.09%	2,686 $416,000
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $44,886 - $51,962	-336 Reduced 11.32%	2,631 $392,000
Q2 2023 Jul 19, 2023	SELL	$132.51 - $164.9 $178,225 - $221,790	-1,345 Reduced 31.19%	2,967 $399,000
Q1 2023 Apr 17, 2023	BUY	$144.61 - $166.54 $23,282 - $26,812	161 Added 3.88%	4,312 $687,000
Q4 2022 Jan 20, 2023	BUY	$138.31 - $165.87 $15,905 - $19,075	115 Added 2.85%	4,151 $0
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $2,013 - $2,308	15 Added 0.37%	4,036 $542,000
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $2,477 - $3,149	18 Added 0.45%	4,021 $616,000
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $2,111 - $2,620	-16 Reduced 0.4%	4,003 $648,000
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $30,187 - $38,196	281 Added 7.52%	4,019 $544,000
Q3 2021 Oct 19, 2021	SELL	$106.4 - $120.78 $16,811 - $19,083	-158 Reduced 4.06%	3,738 $403,000
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $4,524 - $5,040	43 Added 1.12%	3,896 $439,000
Q1 2021 Apr 20, 2021	BUY	$102.3 - $112.62 $160,508 - $176,700	1,569 Added 68.7%	3,853 $417,000
Q4 2020 Jan 28, 2021	SELL	$80.49 - $108.67 $7,807 - $10,540	-97 Reduced 4.07%	2,284 $245,000
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $4,035 - $5,399	-55 Reduced 2.26%	2,381 $234,000
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $11,158 - $16,917	173 Added 7.64%	2,436 $185,000
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $5,265 - $6,588	-73 Reduced 3.13%	2,263 $200,000
Q3 2019 Oct 11, 2019	BUY	$62.98 - $75.72 $6,109 - $7,344	97 Added 4.33%	2,336 $177,000
Q2 2019 Jul 18, 2019	SELL	$65.7 - $83.98 $97,761 - $124,962	-1,488 Reduced 39.92%	2,239 $163,000
Q1 2019 Apr 17, 2019	SELL	$77.14 - $90.79 $771 - $907	-10 Reduced 0.27%	3,727 $300,000
Q4 2018 Jan 18, 2019	BUY	$77.85 - $96.01 $856 - $1,056	11 Added 0.3%	3,737 $345,000
Q3 2018 Oct 12, 2018	SELL	$88.91 - $98.84 $28,184 - $31,332	-317 Reduced 7.84%	3,726 $352,000
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $9,201 - $12,321	-100 Reduced 2.41%	4,043 $383,000
Q4 2017 Jan 16, 2018	BUY	$89.56 - $98.21 $17,912 - $19,642	200 Added 5.07%	4,143 $401,000
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $275,418 - $351,794	3,943	3,943 $350,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.

Account

Gemmer Asset Management LLC Abb Vie Inc. Transaction History